Literature DB >> 17066202

Clinical characteristics of group B streptococcus bacteremia in non-pregnant adults.

Cheng-Mao Ho1, Chih-Yu Chi, Mao-Wang Ho, Chin-Ming Chen, Wei-Chih Liao, Yuag-Meng Liu, Po-Chang Lin, Jen-Hsien Wang.   

Abstract

BACKGROUND AND
PURPOSE: Group B streptococcus (GBS) [Streptococcus agalactiae] is an emerging cause of disease in non-pregnant adults with underlying diseases. This retrospective study analyzed 90 episodes of GBS bacteremia in adults occurring over a 4-year period.
METHODS: Basic and clinical data were collected by reviewing medical charts of patients. Blood cultures were performed on admission of patients suspected of bacteremia. Presence of underlying diseases, such as liver disease, heart disease, urinary tract disorders, and female-specific cancers, as well as possible portals of entry of infection was analyzed.
RESULTS: In 56 episodes (62.2%), patients were aged 60 years or older and 40 (44.4%) episodes occurred in males. Skin and soft tissue were the most common sources of GBS bacteremia (22/90, 24.4%). GBS bacteremia was classified as primary in 50% of the episodes (45 patients). Liver diseases were more common in males, while malignancy was more common in females. Portals of entry with a significant gender predominance included skin and soft tissue in women (p=0.018), bone and joint in women (p=0.016), and urinary tract in men (p=0.042). The overall mortality rate was 18.9% and the attributable mortality rate was 7.8%.
CONCLUSIONS: Elderly people and those with underlying diseases are particularly susceptible to GBS infections. Preventive strategies, including GBS vaccine and skin care, are likely to be particularly important in these high-risk groups.

Entities:  

Mesh:

Year:  2006        PMID: 17066202

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

2.  Molecular typing of colonizing Streptococcus agalactiae strains by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) in a Chennai based hospital.

Authors:  D K Bishi; S Verghese; R S Verma
Journal:  Indian J Microbiol       Date:  2008-05-28       Impact factor: 2.461

3.  A comparison of Streptococcus agalactiae septic arthritis and non-Streptococcus agalactiae septic arthritis.

Authors:  Victor Tzong Jing Wang; Jiong Hao Tan; Leon Han Pay; Tianyi Wu; Liang Shen; Gavin Kane O'Neill; Veerasingam Prem Kumar
Journal:  Singapore Med J       Date:  2018-10       Impact factor: 1.858

4.  Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.

Authors:  Romanee Chaiwarith; Waree Jullaket; Manasanant Bunchoo; Nontakan Nuntachit; Thira Sirisanthana; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2011-05-25       Impact factor: 3.090

5.  Group B Streptococcus Sequence Type 283 Disease Linked to Consumption of Raw Fish, Singapore.

Authors:  Priyanka Rajendram; Win Mar Kyaw; Yee Sin Leo; Hanley Ho; Wen Kai Chen; Raymond Lin; De Partha Pratim; Hishamuddin Badaruddin; Brenda Ang; Timothy Barkham; Angela Chow
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

6.  Group B Streptococcal Tricuspid Endocarditis: Case Report and Systematic Review.

Authors:  Perry Wengrofsky; Ghassan Mubarak; Nabila Khondakar; Syed Haseeb; David Landman; Suzette Graham-Hill; Angelina Zhyvotovska; Samy I McFarlane
Journal:  Scifed J Cardiol       Date:  2018-12-18

7.  A rare case of right-sided infective endocarditis caused by group B Streptococcus complicated with septic knee arthritis and subcutaneous abscess in the lower extremity.

Authors:  Shinsuke Takeda; Yoshihiro Tanaka; Yosuke Takeichi; Hitoshi Hirata; Akihiko Tabuchi
Journal:  Acute Med Surg       Date:  2019-09-17

8.  Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.

Authors:  Maria del Pilar Crespo-Ortiz; Claudia Rocio Castañeda-Ramirez; Monica Recalde-Bolaños; Juan Diego Vélez-Londoño
Journal:  BMC Infect Dis       Date:  2014-08-03       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.